Aimei Total Operating Expenses from 2010 to 2026
| AFJKU Stock | 67.24 4.21 6.68% |
Total Operating Expenses | First Reported 2010-12-31 | Previous Quarter 1.2 M | Current Value 1.3 M | Quarterly Volatility 459 K |
Check Aimei Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aimei Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.9 K, Other Operating Expenses of 1.3 M or EBIT of 137.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.06. Aimei financial statements analysis is a perfect complement when working with Aimei Health Valuation or Volatility modules.
Check out the analysis of Aimei Health Correlation against competitors. The evolution of Total Operating Expenses for Aimei Health Technology provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Aimei Health compares to historical norms and industry peers.
Latest Aimei Health's Total Operating Expenses Growth Pattern
Below is the plot of the Total Operating Expenses of Aimei Health Technology over the last few years. It is the total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses. Aimei Health's Total Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aimei Health's overall financial position and show how it may be relating to other accounts over time.
| Total Operating Expenses | 10 Years Trend |
|
Total Operating Expenses |
| Timeline |
Aimei Total Operating Expenses Regression Statistics
| Arithmetic Mean | 233,774 | |
| Geometric Mean | 54,982 | |
| Coefficient Of Variation | 196.33 | |
| Mean Deviation | 338,166 | |
| Median | 28,459 | |
| Standard Deviation | 458,958 | |
| Sample Variance | 210.6B | |
| Range | 1.3M | |
| R-Value | 0.66 | |
| Mean Square Error | 125.4B | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 60,425 | |
| Total Sum of Squares | 3.4T |
Aimei Total Operating Expenses History
About Aimei Health Financial Statements
Aimei Health shareholders use historical fundamental indicators, such as Total Operating Expenses, to determine how well the company is positioned to perform in the future. Although Aimei Health investors may analyze each financial statement separately, they are all interrelated. The changes in Aimei Health's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aimei Health's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Operating Expenses | 1.2 M | 1.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aimei Stock Analysis
When running Aimei Health's price analysis, check to measure Aimei Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aimei Health is operating at the current time. Most of Aimei Health's value examination focuses on studying past and present price action to predict the probability of Aimei Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aimei Health's price. Additionally, you may evaluate how the addition of Aimei Health to your portfolios can decrease your overall portfolio volatility.